Callan Capital’s Neurocrine Biosciences NBIX Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-15,000	Closed	-$682K	–	55
2016 Q2	$682K	Sell	15,000 -7,000	-32%	-$318K	0.28%	33
2016 Q1	$870K	Buy	22,000 +7,000	+47%	+$277K	0.36%	30
2015 Q4	$849K	Hold	15,000	–	–	0.34%	33
2015 Q3	$597K	Hold	15,000	–	–	0.32%	32
2015 Q2	$716K	Sell	15,000 -5,000	-25%	-$239K	0.15%	49
2015 Q1	$794K	Sell	20,000 -7,365	-27%	-$292K	0.17%	47
2014 Q4	$611K	Hold	27,365	–	–	0.14%	51
2014 Q3	$429K	Hold	27,365	–	–	0.12%	51
2014 Q2	$406K	Hold	27,365	–	–	0.11%	52
2014 Q1	$441K	Buy	27,365 +5,500	+25%	+$88.6K	0.15%	41
2013 Q4	$204K	Buy	+21,865	New	+$204K	0.08%	44